Dr. Dineo Khabele, Professor and Chair of the Department of Obstetrics & Gynecology at Washington University School of Medicine in St. Louis and member of OCRA’s Scientific Advisory Committee, spoke at our 2020 Ovarian Cancer National Conference about the racial disparities in ovarian cancer incidences and outcomes. While there are more documented cases of ovarian … Continued
Dr. Shannon Westin–Associate Professor in the Department of Gynecologic Oncology and Reproductive Medicine at UT MD Anderson Cancer Center, and Director of Early Drug Development/Phase I Trials–has a motto: Research is what cures cancer. Dr. Westin spoke at our International Gynecologic Cancer Conference, sharing everything from what exactly a clinical trial is and how it … Continued
Once a person has been treated for ovarian cancer, and all traces of the disease have been removed, there is rightful cause for celebration and relief. Still, the possibility of a recurrence is often in the back (or the front) of a patient’s mind. Dr. Stephanie Wethington, gynecologic oncologist at Johns Hopkins Medicine, joined us … Continued
A bright spot in 2020 for the ovarian cancer community has been the ongoing developments in research and treatments. Advances continue to be made, as researchers study the effectiveness of PARP inhibitors as maintenance therapy for ovarian cancer, the most effective way to implement immunotherapy agents, the key factors that can affect the success of … Continued
Want to learn what’s new in ovarian cancer research and care for 2020? Start here. This fall, we hosted our virtual Uniting for Hope Ovarian Cancer National Conference, where experts in the field presented on a wide range of topics– demystifying genetic testing and precision medicine, providing resources for financial support, explaining clinical trials, and … Continued
Get email updates about research news, action alerts, and ways to join the fight.
